Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Boehringer-Ingelheim
Company Monitoring Page for Boehringer-Ingelheim
latest headlines for company on cafepharma
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
Motley Fool
Wed, 01/15/20 - 10:56 am
Tags:
AbbVie
,
Boehringer Ingelheim
,
Skyrizi
,
Novartis
,
Cosentyx
,
psoriasis
Boehringer Ingelheim inks 'Singapore's largest biotech deal,' promising $1B each for a suite of anti-fibrotic IL-11 drugs
Endpoints
Thu, 01/9/20 - 09:59 am
Tags:
Boehringer Ingelheim
,
Singapore
,
fibrotic disease
Boehringer cleared to manufacture BeiGene’s cancer drug for Chinese market
Pharmaforum
Fri, 01/3/20 - 09:45 am
Tags:
Boehringer Ingelheim
,
China
,
BeiGene
,
drug manufacturing
As NASH shifts again, the focus remains on Genfit’s big readout
EP Vantage
Wed, 12/18/19 - 10:53 am
Tags:
NASH
,
Genfit
,
elafibranor
,
Pfizer
,
Boehringer Ingelheim
,
Gilead Sciences
,
Poxel
,
Takeda
,
Intercept Pharma
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Pharmaceutical Business Review
Mon, 12/16/19 - 10:35 am
Tags:
Jardiance
,
Eli Lilly
,
Boehringer Ingelheim
,
type 2 diabetes
,
chronic heart failure
,
clinical trials
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Fri, 12/13/19 - 09:05 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
Farxiga
,
diabetes
,
AstraZeneca
,
heart failure
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
Mon, 11/18/19 - 10:29 am
Tags:
diabetes
,
AHA
,
heart failure
,
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
clinical trials
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
Zacks.com
Thu, 11/14/19 - 10:25 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
FDA
,
Jardiance
,
type 1 diabetes
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Wed, 11/13/19 - 10:02 am
Tags:
Boehringer Ingelheim
,
Eli Lilly
,
Jardiance
,
heart failure
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Tue, 11/5/19 - 10:21 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
diabetes
,
type 2 diabetes
Which big pharma firms are best at digital?
Pharmaforum
Wed, 10/16/19 - 12:28 pm
Tags:
digital pharma
,
Bayer
,
Pfizer
,
Boehringer Ingelheim
Boehringer's VC wing backs anti-cancer virus startup
Fierce Biotech
Tue, 10/15/19 - 10:00 am
Tags:
Abalos Therapeutics
,
arenavirus
,
Boehringer Ingelheim
,
cancer
As developers work on cracking KRAS, Germany's Boehringer has quietly begun testing its pan-KRAS drug in humans
Endpoints
Wed, 10/2/19 - 07:42 pm
Tags:
KRAS
,
cancer
,
Boehringer Ingelheim
Boehringer Ingelheim's Ofev cuts rate of decline by 57% in range of rare lung diseases
Fierce Pharma
Tue, 10/1/19 - 10:59 pm
Tags:
Boehringer Ingelheim
,
Ofev
,
idiopathic pulmonary fibrosis
Boehringer Ingelheim signs retinal disease deal with Inflammasome
Pharmaceutical Business Review
Tue, 09/24/19 - 09:26 am
Tags:
Boehringer Ingelheim
,
Inflammasome Therapeutics
,
retinal disease
EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
Fierce Pharma
Tue, 09/17/19 - 11:00 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
kidney disease
,
JNJ
,
EASD
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Wed, 09/11/19 - 11:41 pm
Tags:
Novo Nordisk
,
diabetes
,
ICER
,
oral semaglutide
,
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
Ozempic
Boehringer Ingelheim’s Ofev secures FDA approval for SSc-ILD
Pharmaceutical Business Review
Mon, 09/9/19 - 10:32 am
Tags:
Ofev
,
SSc-ILD
,
Boehringer Ingelheim
,
FDA
After inking a string of pipeline deals, Boehringer Ingelheim is doing a makeover of the top executive team
Endpoints
Mon, 08/26/19 - 10:53 pm
Tags:
Boehringer Ingelheim
,
R&D
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
Sun, 08/25/19 - 05:10 pm
Tags:
drug pricing
,
Canada
,
Janssen
,
Merck
,
Bayer
,
Servier
,
Boehringer Ingelheim
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.